|
FULC Fulcrum Therapeutics Inc 1680581 |
| Balance Sheet |
|
Current Assets
|
249,923,000 |
|
Assets
|
260,718,000 |
|
Current Liabilities
|
11,044,000 |
|
Liabilities
|
17,684,000 |
|
Equity
|
243,034,000 |
|
Shares Out
|
62,401,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-2,218,000 |
|
Investing Cash Flow
|
32,230,000 |
| Market Analysis |
Market Cap
|
220,274,645 |
|
Price
|
3.02 |
|
BVPS
|
3.89 |
|
PB
|
0.76 |
|
EPS
|
-0.35 |
|
PS
|
0.69 |
|
FCF
|
30,012,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FULC documents filed with the SEC.
FULC Filings
Clear
